Gabius S, Wawotzny R, Wilholm S, Martin U, Wörmann B, Gabius H J
Abteilung Glykobiochemie und Angewandte Tumorlektinologie, Philipps Universität, Germany.
Int J Cancer. 1993 Jul 30;54(6):1017-21. doi: 10.1002/ijc.2910540626.
Cell-surface sugar receptors may participate in interactions of lymphoid cells that influence their adhesive properties and proliferation. Their expression on cells of the pre-B line BLIN-I, the B-lymphoblastoid line Croco II, the myeloma line RPMI 8226 and the T-lymphoblastoid line CCRF-CEM was monitored with a panel of 14 types of chemically glycosylated E. coli beta-galactosidase at a non-saturating ligand concentration. Quantitative differences were determined for the capacity of the different cell types to bind constituents of the carbohydrate part of glycoconjugates. They were corroborated by analyses of binding for lactose-, beta-N-acetylgalactosamine-, beta-N-acetylglucosamine- and fucose-exposing neoglycoenzymes up to saturation levels. Values of dissociation constants of the tetrameric enzyme were in the range of 3-300 nM. Several types of sugar receptor led to carbohydrate-inhibitable adhesion of cells to 6 types of nitrocellulose-immobilized neoglycoprotein, their effectiveness being most obvious for the myeloma cells. Analyses of the carbohydrate-ligand-mediated adhesion of the other cell types revealed a comparatively decreased response. Only a few carbohydrates among the 7 types tested were effective in reducing cell adhesion to a far more complex ligand-bearing matrix than immobilized neoglycoproteins, namely bone-marrow stromal cell layers: sialic acid and N-acetylgalactosamine for B-lymphoblastoid cells and rhamnose for pre-B cells. These cellular interactions may encompass sugar receptors on the stromal cells and other types of molecular recognition in addition to the detected activities on the lymphoid cells.
细胞表面糖受体可能参与淋巴细胞间的相互作用,影响其黏附特性和增殖。使用一组14种化学糖基化的大肠杆菌β-半乳糖苷酶,在非饱和配体浓度下监测前B细胞系BLIN-I、B淋巴母细胞系Croco II、骨髓瘤细胞系RPMI 8226和T淋巴母细胞系CCRF-CEM细胞上它们的表达。测定了不同细胞类型结合糖缀合物碳水化合物部分成分的能力的定量差异。通过分析乳糖、β-N-乙酰半乳糖胺、β-N-乙酰葡糖胺和岩藻糖暴露的新糖酶结合直至饱和水平,证实了这些差异。四聚体酶的解离常数值在3 - 300 nM范围内。几种类型的糖受体导致细胞与6种固定在硝酸纤维素上的新糖蛋白发生碳水化合物抑制性黏附,对骨髓瘤细胞来说其效果最为明显。对其他细胞类型的碳水化合物配体介导的黏附分析显示反应相对降低。在所测试的7种碳水化合物中,只有少数几种能有效降低细胞与比固定化新糖蛋白复杂得多的带有配体的基质(即骨髓基质细胞层)的黏附:B淋巴母细胞的唾液酸和N-乙酰半乳糖胺以及前B细胞的鼠李糖。除了在淋巴细胞上检测到的活性外,这些细胞间相互作用可能还包括基质细胞上的糖受体和其他类型的分子识别。